OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.
Frequently asked questions
What sector does Ok Biotech Co Ltd (4155) operate in?
Ok Biotech Co Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Ok Biotech Co Ltd (4155) current stock price?
As of the latest data, Ok Biotech Co Ltd stock price is NT$15.10, with a previous close of NT$14.80. Ok Biotech Co Ltd gained NT$0.30 in the last trading session, representing a 2.03% increase.
What is Ok Biotech Co Ltd (4155) current market capitalization?
Ok Biotech Co Ltd market cap is approximately 2.11 billion.
What is Ok Biotech Co Ltd (4155) Earnings Per Share (EPS)?
The trailing EPS is NT$0.79.
What is Ok Biotech Co Ltd (4155) Price-to-Earnings (P/E) ratio?
Ok Biotech Co Ltd current P/E ratio is 19.11.
What is Ok Biotech Co Ltd (4155) EBITDA?
Ok Biotech Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 51.67 million.
Does Ok Biotech Co Ltd (4155) pay dividends?
No. Ok Biotech Co Ltd does not pay a dividend.
What is Ok Biotech Co Ltd (4155) beta (volatility) score?
Ok Biotech Co Ltd has a beta of 0.241, indicating lower volatility than the overall market.
